Mazor had been FDA Cleared with the first spinal robotic technology in 2004, and the most recent Renaissance robot was cleared in 2016; proven technology on the market with sales for 12 years before MDT took any stake.
No comparison to being 3 yrs from potential clearance with robot where they’ve been struggling with software for three years.
MDTgot what they wanted for 10 mil with no ongoing royalty payments and will integrate into the own SP using their surgeon console from Hugo. Will make it to market two years ahead of Enos (if ever).
News 
Market Data 
Discover 
